CDKN1A and pulmonary arterial hypertension: In patients with COPD with secondary PAH, there is an increase in SA-β-gal staining, p21 and p16 expression in pulmonary vascular smooth muscle cells, compared with patients with COPD without PAH (Noureddine et al, 2011).